Global Custom Market Research Reports Provider Company

phone

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review

  • Published Date: 06 Sep 2018
  • Number of Pages: 51
  • Category: SWOT Analysis
  • Country: United Kingdom
e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

e-Therapeutics Plc (e-Therapeutics) is a drug discovery and development company with focus on the treatment of cancer and neurodegeneration. It has a proprietary discovery platform based on network pharmacology and chemical biology for the discovery of drugs. The company focuses on immuno-oncology to tackle drug resistance in targeted cancer therapies and anti-infectives. Its under development drugs include ETS-2300, ETS-2400, ETS-3100, ETS-5200, ETS-6700. e-Therapeutics has development centers in Oxford and Newcastle. The company operates through one subsidiary, InRotis Technologies Limited. e-Therapeutics is headquartered in Long Hanborough, England, the UK.

e-Therapeutics Plc Key Recent Developments

Mar 27,2018: e-therapeutics: Full Year Results 2018
Nov 01,2017: e-Therapeutics: Appointment of Director
Sep 26,2017: e-Therapeutics: Interim Results for the 6 Months Ended 31 July 2017
Jul 27,2017: Edison issues update on e-Therapeutics (ETX)
Jul 24,2017: e-Therapeutics Announces Outcome of Strategic Review and Future Plans

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
e-Therapeutics Plc - Key Facts 5
e-Therapeutics Plc - Key Employees 6
e-Therapeutics Plc - Key Employee Biographies 7
e-Therapeutics Plc - Major Products and Services 8
e-Therapeutics Plc - History 9
e-Therapeutics Plc - Company Statement 10
e-Therapeutics Plc - Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 Company Analysis 12
Company Overview 12
e-Therapeutics Plc - Business Description 13
e-Therapeutics Plc - SWOT Analysis 14
SWOT Analysis - Overview 14
e-Therapeutics Plc - Strengths 14
e-Therapeutics Plc - Weaknesses 15
e-Therapeutics Plc - Opportunities 16
e-Therapeutics Plc - Threats 17
e-Therapeutics Plc - Key Competitors 18
Section 3 Company Financial Ratios 19
Financial Ratios - Capital Market Ratios 19
Financial Ratios - Annual Ratios 20
Performance Chart 22
Financial Performance 22
Financial Ratios - Interim Ratios 23
Financial Ratios - Ratio Charts 24
Section 4 Companys Lifesciences Financial Deals and Alliances 25
e-Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25
e-Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 26
e-Therapeutics Plc, Recent Deals Summary 27
Section 5 Companys Recent Developments 28
Mar 27, 2018: e-therapeutics: Full Year Results 2018 28
Nov 01, 2017: e-Therapeutics: Appointment of Director 33
Sep 26, 2017: e-Therapeutics: Interim Results for the 6 Months Ended 31 July 2017 34
Jul 27, 2017: Edison issues update on e-Therapeutics (ETX) 39
Jul 24, 2017: e-Therapeutics Announces Outcome of Strategic Review and Future Plans 40
Apr 19, 2017: e-Therapeutics: Full Year Results 43
Apr 06, 2017: e-Therapeutics : Appointment of Chief Executive Officer 44
Feb 16, 2017: e-Therapeutics Announces Directorate Change 45
Jan 09, 2017: e-Therapeutics: Appointment of Amgen Executive Director as Chief Executive 46
Section 6 Appendix 47
Methodology 47
Ratio Definitions 47
About GlobalData 51
Contact Us 51
Disclaimer 51

List Of Tables


e-Therapeutics Plc, Key Facts 5
e-Therapeutics Plc, Key Employees 6
e-Therapeutics Plc, Key Employee Biographies 7
e-Therapeutics Plc, Major Products and Services 8
e-Therapeutics Plc, History 9
e-Therapeutics Plc, Other Locations 11
e-Therapeutics Plc, Subsidiaries 11
e-Therapeutics Plc, Key Competitors 18
e-Therapeutics Plc, Ratios based on current share price 19
e-Therapeutics Plc, Annual Ratios 20
e-Therapeutics Plc, Annual Ratios (Cont...1) 21
e-Therapeutics Plc, Interim Ratios 23
e-Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25
e-Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 26
e-Therapeutics Plc, Recent Deals Summary 27
Currency Codes 47
Capital Market Ratios 47
Equity Ratios 48
Profitability Ratios 48
Cost Ratios 49
Liquidity Ratios 49
Leverage Ratios 50
Efficiency Ratios 50

List Of Figures


e-Therapeutics Plc, Performance Chart (2014 - 2018) 22
e-Therapeutics Plc, Ratio Charts 24
e-Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25
e-Therapeutics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 26

Royal Mail plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

View Report

Leclanche SA (LECN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

View Report

NEC Corp (6701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports